{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-25-006831","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2025-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.567727+00:00","generated_at":"2026-05-17T07:01:49.232832+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Actuate Therapeutics prices $15M public offering of 2.14M shares at $7.00/share","bullets":["Offers 2,142,858 shares at $7.00/share; gross proceeds ~$15M before discounts and expenses.","Underwriters granted 30-day over-allotment option for up to 321,428 additional shares.","Closing expected September 11, 2025; proceeds for working capital and general corporate purposes.","Directors and executive officers subject to lock-up until December 9, 2025.","Lucid Capital Markets sole book-runner; Titan Partners Group as financial advisor."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-25-006831","json":"https://secwatch.observer/filing/0001683168-25-006831.json","markdown":"https://secwatch.observer/filing/0001683168-25-006831.md","text":"https://secwatch.observer/filing/0001683168-25-006831.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/0001683168-25-006831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000168316825006831/actuate_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:01:49.232832+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}